Ranran Tang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Gene Expression

Long Non Coding Rna

Cell Proliferation

Top Venues

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science 115 (3) (2024)
Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science 115 (3) (2024)
Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science 115 (3) (2024)
Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science (2024)
Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science 115 (3) (2024)
Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang
LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer science 115 (3) (2024)
Jian Cao, Huan Wang, Guangquan Liu, Ranran Tang, Ye Ding, PengFei Xu, Huayu Wang, Juan Miao, Xiaoyan Gu, Suping Han
LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging. Journal of cellular and molecular medicine 25 (2) (2020)
Yina Liao, Yao Gao, An Chang, Zongjuan Li, Huayu Wang, Jing Cao, Wei Gu, Ranran Tang
Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling. Journal of cellular and molecular medicine 24 (20) (2020)